0001104659-19-033437.txt : 20190603 0001104659-19-033437.hdr.sgml : 20190603 20190603160034 ACCESSION NUMBER: 0001104659-19-033437 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190530 FILED AS OF DATE: 20190603 DATE AS OF CHANGE: 20190603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van der Ploeg Leonardus H.T. CENTRAL INDEX KEY: 0001615726 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 19873244 MAIL ADDRESS: STREET 1: 101 HAMMOND STREET CITY: NEWTON STATE: MA ZIP: 02467 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 11TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 11TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 a4.xml 4 X0306 4 2019-05-30 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001615726 Van der Ploeg Leonardus H.T. 222 BERKELEY STREET, SUITE 1200 BOSTON MA 02116 0 1 0 0 Chief Scientific Officer Common Stock 2019-05-30 4 M 0 5000 4.59 A 47339 D Common Stock 2019-05-30 4 S 0 5000 25.31 D 42339 D Common Stock 2019-05-31 4 M 0 5000 4.59 A 47339 D Common Stock 2019-05-31 4 S 0 5000 25.10 D 42339 D Employee Stock Option (Right to Buy) 4.59 2019-05-30 4 M 0 5000 0 A 2025-11-16 Common Stock 5000 13611 D Employee Stock Option (Right to Buy) 4.59 2019-05-31 4 M 0 5000 0 A 2025-11-16 Common Stock 5000 8611 D This transaction was executed in multiple trades at prices ranging from $25.11 to $25.64, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.33, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015. /s/ Hunter S. Smith, attorney-in-fact for Leonardus H.T. Van der Ploeg 2019-06-03